Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 May 17;11(3):20458940211020913.
doi: 10.1177/20458940211020913. eCollection 2021 Jul-Sep.

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry

Affiliations

Health disparities and treatment approaches in portopulmonary hypertension and idiopathic pulmonary arterial hypertension: an analysis of the Pulmonary Hypertension Association Registry

Hilary M DuBrock et al. Pulm Circ. .

Erratum in

Abstract

Compared to idiopathic pulmonary arterial hypertension (IPAH), patients with portopulmonary hypertension (POPH) have worse survival. Health disparities may contribute to these differences but have not been studied. We sought to compare socioeconomic factors in patients with POPH and IPAH and to determine whether socioeconomic status and/or POPH diagnosis were associated with treatment and health-care utilization. We performed a cross-sectional study of adults enrolled in the Pulmonary Hypertension Association Registry. Patients with IPAH (n = 344) and POPH (n = 57) were compared. Compared with IPAH, patients with POPH were less likely to be college graduates (19.6% vs. 34.9%, p = 0.02) and more likely to be unemployed (54.7% vs. 30.5%, p < 0.001) and have an annual household income below poverty level (45.7% vs. 19.0%, p < 0.001). Patients with POPH had similar functional class, quality of life, 6-min walk distance, and mean pulmonary arterial pressure with a higher cardiac index. Compared with IPAH, patients with POPH were less likely to receive combination therapy (46.4% vs. 62.2%, p = 0.03) and endothelin receptor antagonists (28.6% vs. 55.1%, p < 0.001) at enrollment with similar treatment at follow-up. Patients with POPH had more emergency department visits (1.7 ± 2.1 vs. 0.9 ± 1.2, p = 0.009) and hospitalizations in the six months preceding enrollment (1.5 ± 2.1 vs. 0.8 ± 1.1, p = 0.02). Both POPH diagnosis and lower education level were independently associated with a higher number of emergency department visits. Compared to IPAH, patients with POPH have lower socioeconomic status, are less likely to receive initial combination therapy and endothelin receptor antagonists but have similar treatment at follow-up, and have increased health-care utilization.

Keywords: health-care utilization; pulmonary hypertension; socioeconomic status.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Socioeconomic factors in patients with IPAH and POPH. Compared with IPAH, patients with POPH are significantly less likely to be college graduates, less likely to have an annual household income ≥ $50,000 per year and are more likely to have an annual household income below poverty level and be unemployed.
Fig. 2.
Fig. 2.
Emergency department visits in IPAH and POPH. Least square means for emergency department visits in IPAH and POPH after adjustment for age, functional class, 6-min walk distance, cardiac index, right atrial pressure, and education level. Compared with IPAH, patients with POPH had a higher number of emergency department visits in the six months preceding enrollment in the Pulmonary Hypertension Association Registry (1.5, 95% CI: 1.2–1.9 visits vs. 0.8, 95% CI: 0.7–1.0 visits, p = 0.001).

References

    1. Rodriguez-Roisin R, Krowka MJ, Herve P, et al.. Pulmonary-hepatic vascular disorders (PHD). Eur Respir J 2004; 24: 861–880. - PubMed
    1. Simonneau G, Montani D, Celermajer DS, et al.. Haemodynamic definitions and updated clinical classification of pulmonary hypertension. Eur Respir J 2019; 53. - PMC - PubMed
    1. Badesch DB, Raskob GE, Elliott CG, et al.. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010; 137: 376–387. - PubMed
    1. Krowka MJ, Fallon MB, Kawut SM, et al.. International liver transplant society practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension. Transplantation 2016; 100: 1440–1452. - PubMed
    1. Krowka MJ, Plevak DJ, Findlay JY, et al.. Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl 2000; 6: 443–450. - PubMed

LinkOut - more resources